Published in Medicine and Law Weekly, July 1st, 2005
Approximately 90% of patients maintained or improved vision (defined as a loss of less than 15 letters in visual acuity) when treated with the combination of Lucentis and PDT compared to approximately 68% of those treated in the control arm of PDT alone (p =3D 0.0003).
Patients treated with Lucentis plus PDT at 12 months had, on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.